GLP-1 Clinical Relevance #42Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical ResearchObservational StudyGallstone DiseaseInsulin ResistanceEndocrinologyAdults with ObesityMetabolic Syndrome RiskIncretin EffectMETS-IR ScoreU-Shaped AssociationMetabolic Scoring ToolsCholelithiasis Incidence...
GLP-1 Receptor Agonist Clinical Evidence on Optimal Body Fat
GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational StudyMetabolic HealthInsulin ResistanceEndocrinologyAdults with ObesityBody Composition OutcomesFat Distribution PathwaysLow Body Fat RiskVisceral FatMetabolic...
GLP-1 Clinical Evidence: Insulin Resistance in Childhood Obesity
GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Longitudinal StudyCohort StudyInsulin ResistanceChildhood ObesityPediatric PatientsEndocrinologyCardiometabolic RiskEpigenetic MarkersDNA MethylationMetabolic Health TrajectoriesPediatric Metabolic DiseaseBiomarker Discovery Why...
GLP-1 Clinical Evidence: Adolescent Metabolic Health
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Consensus StatementObservationalAdolescent Metabolic HealthType 2 Diabetes PreventionObesity PreventionPediatric PatientsInsulin ResistanceIncretin EffectEndocrinologyPediatric ObesityMetabolic...
GLP-1 & Metabolic Health: Fatty Liver Causes Explained
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Metabolic-Associated Steatotic Liver DiseaseNewsObservationalFatty Liver DiseaseInsulin ResistanceEndocrinologyAdults with ObesityHepatic OutcomesIncretin EffectType 2...
GLP-1 Digest: Latest Research and Clinical Updates April 16,
Clinical Takeaway This issue examines a convergence of compelling evidence across metabolic medicine, with new research strengthening the case for GLP-1 receptor agonists in liver disease management, weight loss optimization, and diabetes...
Metformin & Insulin Resistance: Diabetes Prevention Evidence
GLP-1 Clinical Relevance #46Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical NewsObservational StudyPrediabetesMetforminEndocrinologyAdults with ObesityDiabetes PreventionInsulin ResistanceClustering AnalysisHigh-Risk PhenotypeMetabolic StratificationPrecision Medicine Why...